Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Pew Health Group to ensure safety of U.S. drug supply

On Wednesday, September 14, Allan Coukell, a pharmacist and director of medical programs at the Pew Health Group, will testify before the Senate Health Education Labor and Pensions Committee about the need for Congressional action to ensure the safety of the U.S. drug supply.

12 Sep 2011

Diamyd receives NIH grant to develop NTDDS for Chemotherapy Induced Peripheral Neuropathy

Diamyd Medical AB with collaborators has received a three million dollar grant from the US National Institutes of Health to develop the Company's patented Nerve Targeting Drug Delivery System (NTDDS) for prevention of Chemotherapy Induced Peripheral Neuropathy.

12 Sep 2011

PharmAthene completes 1,500 liter engineering production run for SparVax anthrax vaccine

PharmAthene, Inc. announced today that it has achieved significant progress in the development of its second generation anthrax vaccine, SparVax.

12 Sep 2011

UMSOM to receive FDA approval for whole parasite malaria vaccine clinical trials

For the first time, a malaria vaccine that uses the entire malaria parasite has proven safe and shown promise to produce a strong immune response in a clinical trial, according to a new study co-authored by researchers at the University of Maryland School of Medicine Center for Vaccine Development.

12 Sep 2011

Patheon third quarter revenues increase 5.8% to $172.7 million

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today: Details of Patheon's new corporate strategy, including an initial heavy focus on strengthening the company's core operations.

9 Sep 2011

Astex selects PharmaVentures to assist in divesment of CMC & Formulation Facility

PharmaVentures Limited, experts in deals and alliances, are pleased to announce that they have been engaged by leading drug discovery company, Astex Pharmaceuticals to seek a buyer for an established full service CMC & Formulation Facility in Pleasanton, California. The engagement will utilise PharmaVentures' asset divestment expertise in the life sciences sector.

9 Sep 2011

As Obama readies jobs plan, health sector leads pack

President Barack Obama will unveil a new jobs plan today. News outlets report on how health jobs are one clear area of promise.

9 Sep 2011

Positive results from Sanaria PfSPZ Vaccine initial Phase 1 trial on malaria

Positive results from the initial Phase 1 clinical trial in 80 healthy volunteers and complementary pre-clinical studies of the Sanaria PfSPZ Vaccine are published today in the online issue of Science.

9 Sep 2011

Curbing unhealthy eating to reduce obesity

The Obesity Policy Coalition suggests a new mobile app called Traffic Light Food Tracker that will enable users to work around the food industry's hesitation in supporting traffic light labeling. Traffic light labeling marks foods high in fat, sugar and salt with red warnings, while green labels are for healthy options. Users only have to key in their food item's fat, sugar and sodium quantities and save each item in their “pantry” within the phone app.

8 Sep 2011

Nexera to submit amended claims for FDA 510(k) clearance of SpectraShield 9500 Surgical N95 Respirator

Nexera Medical, Inc., today announced plans to submit to the U.S. Food and Drug Administration amended antimicrobial claims for its current 510(k) clearance for the SpectraShield 9500 Surgical N95 Respirator with embedded antimicrobial technology. The expanded antimicrobial claims will be supported by test data on the inactivation performance of certain strains of viruses.

8 Sep 2011

Building up public sector in Haiti key to controlling cholera

The U.N.'s Pan-American Health Organization, the United States and the international community "should be working with the Haitian Health Ministry to wage a more aggressive and effective effort" against the cholera epidemic that hit the country last year, and those efforts "should include not only clean water and sanitation systems but more antibiotics and cholera vaccinations," a New York Times editorial says.

8 Sep 2011

Pharnext puts together €2.5M to fund development of Pleodrug for Charcot-Marie-Tooth disease

Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments based on Pleotherapy for severe neurological diseases, today announced that it has put together a €2.5 million round of financing (corresponding to a pre-money company valuation of €60 million).

8 Sep 2011

Pall inaugurates new Singapore Life Sciences Centre of Excellence

Pall Corporation, a global leader in filtration, separation and purification, today inaugurated its Pall Life Sciences Centre of Excellence in Singapore, the latest addition to the company's global customer support network.

From Pall Corporation 8 Sep 2011

Ardea Biosciences reports positive outcome from lesinurad End-of-Phase 2 meetings with FDA

Ardea Biosciences, Inc. announced that it has completed formal End-of-Phase 2 meetings with the U.S. Food and Drug Administration (FDA) and successfully reached agreement on the following key aspects of its proposed lesinurad Phase 3 development plan: the overall size and design of the planned Phase 3 clinical studies, the primary endpoints, the total safety database proposed for NDA filing, manufacturing plans for both drug substance and drug product, the preclinical toxicology program and the clinical pharmacology program.

7 Sep 2011

BARDA awards GlaxoSmithKline contract for development of dual-purpose broad spectrum antibiotic

The federal government today issued a contract for advanced research and development of a dual-purpose broad spectrum antibiotic with potential to treat illnesses caused by bioterrorism threats such as plague and tularemia, as well as more certain life-threatening infections, known as Gram-negative infections, associated with prolonged hospitalization.

7 Sep 2011

Drugs produced in offshore manufacturing plants more likely to have quality problems

Drugs produced in offshore manufacturing plants -- even those run by U.S. manufacturers -- pose a greater quality risk than those prepared in the mainland United States, a new study suggests.

7 Sep 2011

Viewpoints: Analyzing Texas' health insurance record; advice for 'super' committee; one doc's cancer experience

Targeting waste, fraud and abuse; eliminating unnecessary and duplicative spending; and ending military adventurism need not be accompanied by slashing essential services such as education and shredding our social safety nets - Social Security, Medicare and Medicaid.

7 Sep 2011

AMT, NIH enter exclusive license agreement for use of AAV5-based gene therapy vectors

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today announced that it has entered into an exclusive license agreement with the US National Institutes of Health (NIH) for use of adeno-associated virus serotype 5 (AAV5)-based gene therapy vectors for liver and brain indications.

6 Sep 2011

Lilly, QIAGEN partner to develop and commercialize companion diagnostic for JAK2 V617F

QIAGEN today announced that it has entered into a partnership with Eli Lilly and Company for the development, manufacturing and commercialization of a molecular companion diagnostic for an early stage investigational compound currently being developed by Lilly. Financial terms of the agreement were not disclosed.

From QIAGEN Manchester Limited 6 Sep 2011

Western, Midwestern states register higher methamphetamine usage

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today issued its annual report on U.S. worker drug use, the Quest Diagnostics Drug Testing Index.

From Quest Diagnostics 2 Sep 2011

Manufacturing News and Research

Further Reading

Pew Health Group to ensure safety of U.S. drug supply

Diamyd receives NIH grant to develop NTDDS for Chemotherapy Induced Peripheral Neuropathy

PharmAthene completes 1,500 liter engineering production run for SparVax anthrax vaccine

UMSOM to receive FDA approval for whole parasite malaria vaccine clinical trials

Patheon third quarter revenues increase 5.8% to $172.7 million

Astex selects PharmaVentures to assist in divesment of CMC & Formulation Facility

As Obama readies jobs plan, health sector leads pack

Positive results from Sanaria PfSPZ Vaccine initial Phase 1 trial on malaria

Curbing unhealthy eating to reduce obesity

Nexera to submit amended claims for FDA 510(k) clearance of SpectraShield 9500 Surgical N95 Respirator

Building up public sector in Haiti key to controlling cholera

Pharnext puts together €2.5M to fund development of Pleodrug for Charcot-Marie-Tooth disease

Pall inaugurates new Singapore Life Sciences Centre of Excellence

Ardea Biosciences reports positive outcome from lesinurad End-of-Phase 2 meetings with FDA

BARDA awards GlaxoSmithKline contract for development of dual-purpose broad spectrum antibiotic

Drugs produced in offshore manufacturing plants more likely to have quality problems

Viewpoints: Analyzing Texas' health insurance record; advice for 'super' committee; one doc's cancer experience

AMT, NIH enter exclusive license agreement for use of AAV5-based gene therapy vectors

Lilly, QIAGEN partner to develop and commercialize companion diagnostic for JAK2 V617F

Western, Midwestern states register higher methamphetamine usage

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy